María José Casanova

Author

María José Casanova

Hospital Universitario de La Princesa ORCID

Also Known As

B. Botella, Barreiro de Acosta, Manuel, C Chavarra-Herbozo, Casa-Nova, Maria José, Eva Iglesias, M Casanova, M J Casanova, M. Casanova, M. J. Casanova, M.J. Casanova

204

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de La Princesa Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Universidad Autónoma de Madrid Hospital Universitari i Politècnic La Fe Complejo Hospitalario Universitario de Santiago

About

María José Casanova is an author at Hospital Universitario de La Princesa specializing in medicine, gastroenterology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	162
2	Gastroenterology	2	2	131
3	Immunology	1	1	31
4	Pathology	1	1	31
5	Autoimmune Disease	1	1	31

María José Casanova

Publications

Citations

H-Index

Page 1

	Year	Citations
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment Hannah Gordon, Silvia Minozzi, Uri Kopylov, Journal of Crohn s and Colitis	2024	240
Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease María José Casanova, María Chaparro, Eugeni Domènech, The American Journal of Gastroenterology	2013	232
Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease María José Casanova, María Chaparro, Begoña Molina, Journal of Crohn s and Colitis	2017	180
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study María Chaparro, A Verreth, Triana Lobatón, The American Journal of Gastroenterology	2018	167
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment Michel Adamina, Silvia Minozzi, Janindra Warusavitarne, Journal of Crohn s and Colitis GastroenterologyVisceral SurgerySurgeryUpper Gastrointestinal SurgeryEcco Guidelines	2024	114
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study María José Casanova, María Chaparro, Valle García–Sánchez, The American Journal of Gastroenterology	2016	112
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry María Chaparro, A Garre, Francisco Mesonero, Journal of Crohn s and Colitis	2020	101
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study Carlos Chavarría, María José Casanova, María Chaparro, Journal of Crohn s and Colitis	2019	96
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study María Chaparro, Ana Garre, Andrea Núñez Ortiz, Journal of Clinical Medicine	2021	92
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry María Chaparro, A Garre, Marisa Iborra, Journal of Crohn s and Colitis	2021	79

Page 1